Cargando…
Optimizing post-operative Crohn’s disease treatment
Despite the availability of biological drugs and the widespread and earlier use of immunosuppressants, intestinal resection remains necessary in almost half of the patients with Crohn’s disease. The development of new mucosal lesions in previously unaffected intestinal segments (a phenomenon known a...
Autores principales: | Domènech, Eugeni, Mañosa, Míriam, Lobatón, Triana, Cabré, Eduard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188927/ https://www.ncbi.nlm.nih.gov/pubmed/25331779 |
Ejemplares similares
-
Editorial: Postoperative management of Crohn's disease: One size does not fit all
por: Domènech, Eugeni, et al.
Publicado: (2023) -
Interleukin-10 Enhances the Intestinal Epithelial Barrier in the Presence of Corticosteroids through p38 MAPK Activity in Caco-2 Monolayers: A Possible Mechanism for Steroid Responsiveness in Ulcerative Colitis
por: Lorén, Violeta, et al.
Publicado: (2015) -
Terminal ileitis is not always Crohn’s disease
por: Bojic, Daniela, et al.
Publicado: (2011) -
Minimally invasive surgery in Crohn’s disease
por: Bazzi, Piero, et al.
Publicado: (2011) -
Small bowel enteroscopy in Crohn’s disease
por: Moreels, Tom G.
Publicado: (2012)